Responsiveness of the VAS and McGill Pain Questionnaire in Measuring Changes in Musculoskeletal Pain

Chaffee, Amy; Yakuboff, Mariel K.; Tanabe, Tomomi

doi:10.1123/jsr.20.2.250

Cited by 30 publications

(18 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The resolution or return of symptoms was noted at the 6-week visit using a scoring system between 0% to 100% improvement. DASH scores [11], VAS scores [4], and resolution or return of symptoms were noted at the 6-month visit.…”

Section: Methodsmentioning

confidence: 99%

Ultrasound-guided Injections for de Quervain’s Tenosynovitis

McDermott

Ilyas

Nazarian

et al. 2012

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

show abstract

Section: Methodsmentioning

confidence: 99%

Ultrasound-guided Injections for de Quervain’s Tenosynovitis

McDermott

Ilyas

Nazarian

et al. 2012

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

show abstract

“…The high frequency of women among the TMD participants in our study is supported by t he l ite rat u r e, r ep or t i ng t h at 9 0% a r e female. 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,25 There are many factors that contribute to the development of TMD, according to Okeson 1 and Leeuw, 26 primarily: occlusion conditions, trauma, emotional distress, and parafunctional habits (clenching and bruxism). Stress symptoms are associated with the development of TMD, and the manifestation of pain could be the chief cause of TMD 27,28 , as observed in our sample.…”

Section: Discussionmentioning

confidence: 99%

The analgesic effect of photobiomodulation therapy (830 nm) on the masticatory muscles: a randomized, double-blind study

et al. 2017

View full text Add to dashboard Cite

This study assesses the efficacy of photobiomodulation therapy (830 nm) for myalgia treatment of masticatory muscles. Sixty patients with muscular myalgia were selected and randomly allocated into 2 groups (n=30): Group A comprised patients given a placebo (control), and Group B consisted of those undergoing photobiomodulation therapy (PBMT). PBMT and placebo were applied bilaterally to specific points on the masseter and temporal muscles. Referred pain elicited by palpation and maximum mouth opening were measured before (EV1) and after (EV2) the treatments. The data were analyzed using statistical tests, considering a significance level of 5%. No significant differences in range were observed for active or passive mouth opening (p ≥ 0.05). Comparing the final outcomes (EV1-EV2) of both treatments, statistical significance was verified for total pain in the right masseter muscle (p = 0.001) and total pain (p = 0.005). In EV2, significant differences in pain reported with palpation were found between Groups A and B for the following: left posterior temporal muscle (p = 0.025), left superior masseter muscle (p = 0.036), inferior masseter muscle (p = 0.021), total pain (left side) (p = 0.009), total masseter muscle (left side) (p = 0.014), total temporal (left side) (p = 0.024), and total pain (p = 0.035). We concluded that PBMT (830 nm) reduces pain in algic points, but does not influence the extent of mouth opening in patients with myalgia.

show abstract

“…The Visual Analog Scale is a common tool used in rehabilitation populations to measure pain and fatigue. The VAS has good psychometric properties (reliability: 0Á71-0Á94; validity: 0Á71-0Á91) and is sensitive to change in pain and inflammatory conditions (Hartrick et al 2003, Chaffee et al 2011, Hawker et al 2011.…”

Section: Methodsmentioning

confidence: 99%